Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer

Jorge R. Caso; Matvey Tsivian; Vladimir Mouraviev; Thomas J. Polascik; Judd W. Moul

doi:10.1111/j.1464-410X.2010.09439.x

Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer

Jorge R. Caso, Matvey Tsivian, Vladimir Mouraviev, Thomas J. Polascik, Judd W. Moul

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	BJUI
Volume	106
DOIs	https://doi.org/10.1111/j.1464-410X.2010.09439.x
State	Published - Jan 12 2010
Externally published	Yes

Disciplines

Medicine and Health Sciences
Surgery
Urology

Access to Document

10.1111/j.1464-410X.2010.09439.xLicense: Unspecified

Cite this

@article{d5996710b3674364a29959eb7514f390,

title = "Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer",

author = "Caso, \{Jorge R.\} and Matvey Tsivian and Vladimir Mouraviev and Polascik, \{Thomas J.\} and Moul, \{Judd W.\}",

note = "Judd W Moul, MD, Division of Urologic Surgery, Duke University Medical Center, Box 3707, Room 1573, Duke South-White Zone, Durham, NC 27710, USA.e-mail: [email protected] Study Type - Prognosis (case series)Level of Evidence 4 To determine the adequacy of T2 prostate cancer (PCa) sub-staging as an independent Predictor of biochemical disease-free survival (bDFS) after radical prostatectomy.",

year = "2010",

month = jan,

day = "12",

doi = "10.1111/j.1464-410X.2010.09439.x",

language = "American English",

volume = "106",

journal = "BJUI",

}

TY - JOUR

T1 - Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer

AU - Caso, Jorge R.

AU - Tsivian, Matvey

AU - Mouraviev, Vladimir

AU - Polascik, Thomas J.

AU - Moul, Judd W.

N1 - Judd W Moul, MD, Division of Urologic Surgery, Duke University Medical Center, Box 3707, Room 1573, Duke South-White Zone, Durham, NC 27710, USA.e-mail: [email protected] Study Type - Prognosis (case series)Level of Evidence 4 To determine the adequacy of T2 prostate cancer (PCa) sub-staging as an independent Predictor of biochemical disease-free survival (bDFS) after radical prostatectomy.

PY - 2010/1/12

Y1 - 2010/1/12

UR - http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2010.09439.x/full

U2 - 10.1111/j.1464-410X.2010.09439.x

DO - 10.1111/j.1464-410X.2010.09439.x

M3 - Article

VL - 106

JO - BJUI

JF - BJUI

ER -

Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer

Disciplines

Access to Document

Other files and links

Cite this